Agilent/Dako

Mutated melanoma-associated antigen 1

#M7259 · western blot

26
Citing papers
899
Combined citations
Supplier page Find this product

Research areas

Lymphoma Diagnosis and Treatment13CNS Lymphoma Diagnosis and Treatment8Glioma Diagnosis and Treatment3Cutaneous lymphoproliferative disorders research3Monoclonal and Polyclonal Antibodies Research3Genetic factors in colorectal cancer2Brain Metastases and Treatment2Cancer Immunotherapy and Biomarkers2

Papers citing this product

1
Clinicopathological and protein characterization of <i>BRAF</i>‐ and <i>K‐RAS</i>‐mutated colorectal cancer and implications for prognosis
International Journal of Cancer·2010·172 cit.·DOI
2
The genomic and transcriptional landscape of primary central nervous system lymphoma
Nature Communications·2022·139 cit.·DOI
3
IRF-4 and c-Rel expression in antiviral-resistant adult T-cell leukemia/lymphoma
Blood·2006·77 cit.·DOI
4
Synergistic Anti-Tumor Activity of EZH2 Inhibitors and Glucocorticoid Receptor Agonists in Models of Germinal Center Non-Hodgkin Lymphomas
PLoS ONE·2014·74 cit.·DOI
5
GAPDH Expression Predicts the Response to R-CHOP, the Tumor Metabolic Status, and the Response of DLBCL Patients to Metabolic Inhibitors
Cell Metabolism·2019·71 cit.·DOI
6
Role of microRNAs and microRNA machinery in the pathogenesis of diffuse large B-cell lymphoma
Blood Cancer Journal·2013·63 cit.·DOI
7
Selective antisense oligonucleotide inhibition of human IRF4 prevents malignant myeloma regeneration via cell cycle disruption
Cell stem cell·2021·62 cit.·DOI
8
TIA-1 Cytotoxic Granule-Associated RNA Binding Protein Improves the Prognostic Performance of CD8 in Mismatch Repair-Proficient Colorectal Cancer
PLoS ONE·2010·58 cit.·DOI
9
A Phase I Clinical Trial of Systemically Delivered NEMO Binding Domain Peptide in Dogs with Spontaneous Activated B-Cell like Diffuse Large B-Cell Lymphoma
PLoS ONE·2014·45 cit.·DOI
10
BCL2 Expression Is a Prognostic Marker for the Activated B-Cell-Like Type of Diffuse Large B-Cell Lymphoma.
Blood·2006·39 cit.·DOI
Mutated melanoma-associated antigen 1 — Evidence — PubIndex